NYBC Ventures
Boston, MA · Seed → Series B
Their stated focus (public profile)
NYBC Ventures is a $50M fund launched by New York Blood Center Enterprises that invests in early to mid-stage innovations in blood and cellular therapies and related technologies. The fund focuses on hematology, transfusion medicine, cell therapy, and infectious disease. It supports therapeutics, devices, and other breakthrough solutions that address key challenges in these fields, leveraging New York Blood Center's deep scientific expertise.
Stages: Seed → Series B
Sectors: Healthtech, Hematology, Life sciences
On file: 8 partners on record
Website: nybcventures.com
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Is this your fund? Request a correction or removal.
Search the funds we have on file
Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.
Looking to claim your own fund? Start here →
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Funds closest to this thesis
Ordered by how close each thesis sits to this one.
Is this your fund? Request a correction or removal.